Roy Guharoy

573 total citations
36 papers, 375 citations indexed

About

Roy Guharoy is a scholar working on Pediatrics, Perinatology and Child Health, Geriatrics and Gerontology and Infectious Diseases. According to data from OpenAlex, Roy Guharoy has authored 36 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pediatrics, Perinatology and Child Health, 9 papers in Geriatrics and Gerontology and 8 papers in Infectious Diseases. Recurrent topics in Roy Guharoy's work include Pharmaceutical studies and practices (10 papers), Pharmaceutical Practices and Patient Outcomes (9 papers) and Antibiotic Use and Resistance (7 papers). Roy Guharoy is often cited by papers focused on Pharmaceutical studies and practices (10 papers), Pharmaceutical Practices and Patient Outcomes (9 papers) and Antibiotic Use and Resistance (7 papers). Roy Guharoy collaborates with scholars based in United States, Australia and Germany. Roy Guharoy's co-authors include Joseph J. Medicis, John Noviasky, David F. Lehmann, William Darko, Adrienne Smith, Edward P. Krenzelok, Robert W. Finberg, Nancy Newman, Michelle D. Wiest and David B. Duggan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Infectious Diseases.

In The Last Decade

Roy Guharoy

31 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roy Guharoy United States 11 95 79 55 55 54 36 375
E. Salas Spain 11 111 1.2× 100 1.3× 58 1.1× 45 0.8× 34 0.6× 30 370
Evelyn Deasy Ireland 9 125 1.3× 73 0.9× 123 2.2× 79 1.4× 32 0.6× 17 325
Dennis Grauer United States 12 191 2.0× 107 1.4× 25 0.5× 101 1.8× 50 0.9× 33 533
Teresa J. Lubowski United States 8 153 1.6× 53 0.7× 54 1.0× 58 1.1× 58 1.1× 15 579
Matthew J. Labreche United States 14 52 0.5× 94 1.2× 46 0.8× 40 0.7× 27 0.5× 16 515
Vicky Dudas United States 7 137 1.4× 46 0.6× 34 0.6× 60 1.1× 34 0.6× 7 469
Chien‐Chih Wu Taiwan 12 82 0.9× 96 1.2× 142 2.6× 43 0.8× 99 1.8× 33 408
Barbara Claus Belgium 10 128 1.3× 42 0.5× 150 2.7× 116 2.1× 62 1.1× 25 495
Jason W. Lancaster United States 12 88 0.9× 65 0.8× 48 0.9× 47 0.9× 45 0.8× 22 493
Sara D. Brouse United States 10 87 0.9× 158 2.0× 132 2.4× 14 0.3× 29 0.5× 26 492

Countries citing papers authored by Roy Guharoy

Since Specialization
Citations

This map shows the geographic impact of Roy Guharoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Guharoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Guharoy more than expected).

Fields of papers citing papers by Roy Guharoy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Guharoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Guharoy. The network helps show where Roy Guharoy may publish in the future.

Co-authorship network of co-authors of Roy Guharoy

This figure shows the co-authorship network connecting the top 25 collaborators of Roy Guharoy. A scholar is included among the top collaborators of Roy Guharoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy Guharoy. Roy Guharoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guharoy, Roy & John Noviasky. (2021). Executive Order on Ensuring Essential Medicines—All Bark, No Bite?. Mayo Clinic Proceedings. 96(7). 1714–1717. 1 indexed citations
2.
Finberg, Robert W. & Roy Guharoy. (2021). Clinical Use of Anti-infective Agents. 2 indexed citations
3.
Guharoy, Roy, Edward P. Krenzelok, & John Noviasky. (2020). Race Against the Pandemic: The United States and Global Health. Journal of Emergency Medicine. 60(3). 402–406. 1 indexed citations
4.
Guharoy, Roy & Edward P. Krenzelok. (2020). Searching for COVID-19 treatments: First, do no harm. American Journal of Health-System Pharmacy. 77(22). 1899–1905. 2 indexed citations
5.
Guharoy, Roy & Edward P. Krenzelok. (2020). US Food and Drug Administration (FDA) Emergency Use Authorization: Glass Half Full or Glass Half Empty?. Clinical Infectious Diseases. 73(3). 549–552. 6 indexed citations
6.
Jacobi, Judith, Shaunta’ M. Ray, Elizabeth Dodds Ashley, et al.. (2016). Impact of the Pharmacy Practice Model Initiative on Clinical Pharmacy Specialist Practice. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 36(5). e40–9. 24 indexed citations
7.
Guharoy, Roy, et al.. (2016). What Antimicrobial Stewardship Interventions Are We Focusing on? The Experience of a Large Healthcare System. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations
8.
Guharoy, Roy, John Noviasky, Ziad Haydar, Mohamad G. Fakih, & Christian Hartman. (2013). Compounding Pharmacy Conundrum. CHEST Journal. 143(4). 896–900. 14 indexed citations
9.
Finberg, Robert W. & Roy Guharoy. (2012). Clinical Use of Anti-infective Agents. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 5 indexed citations
10.
Polk, Ronald E., et al.. (2012). Antibiogram compliance in University HealthSystem Consortium participating hospitals with Clinical and Laboratory Standards Institute guidelines. American Journal of Health-System Pharmacy. 69(7). 598–606. 30 indexed citations
11.
12.
Lehmann, David F., Roy Guharoy, Joseph J. Medicis, et al.. (2007). Every Error a Treasure: Improving Medication Use with a Nonpunitive Reporting System. The Joint Commission Journal on Quality and Patient Safety. 33(7). 401–407. 23 indexed citations
13.
Lehmann, David F., Christine M. Stork, & Roy Guharoy. (2006). Hospital Pharmacology: An Alternative Model for Practice and Training in Clinical Pharmacology. The Journal of Clinical Pharmacology. 46(8). 850–854. 8 indexed citations
14.
Guharoy, Roy, et al.. (2004). West Nile virus infection. American Journal of Health-System Pharmacy. 61(12). 1235–1241. 13 indexed citations
15.
Marraffa, Jeanna M., et al.. (2003). Vancomycin‐Induced Thrombocytopenia: A Case Proven with Rechallenge. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(9). 1195–1198. 20 indexed citations
16.
Noviasky, John, et al.. (2003). Science or Fiction: Use of Nesiritide as a First‐Line Agent?. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(8). 1081–1083. 10 indexed citations
17.
Darko, William, Joseph J. Medicis, Adrienne Smith, Roy Guharoy, & David F. Lehmann. (2003). Mississippi Mud No More: Cost‐Effectiveness of Pharmacokinetic Dosage Adjustment of Vancomycin to Prevent Nephrotoxicity. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(5). 643–650. 63 indexed citations
18.
Marraffa, Jeanna M. & Roy Guharoy. (2002). Lymphadenopathy secondary to lamotrigine (Lamictal).. PubMed. 44(5). 276–7. 3 indexed citations
19.
Guharoy, Roy, et al.. (1999). Methamphetamine overdose: experience with six cases.. PubMed. 41(1). 28–30. 5 indexed citations
20.
Guharoy, Roy, et al.. (1998). Fatal adverse event secondary to high osmolality contrast agent.. PubMed. 40(5). 285–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Salas Breakdown of academic impact, for papers by Evelyn Deasy Breakdown of academic impact, for papers by Dennis Grauer Breakdown of academic impact, for papers by Teresa J. Lubowski Breakdown of academic impact, for papers by Matthew J. Labreche Breakdown of academic impact, for papers by Vicky Dudas Breakdown of academic impact, for papers by Chien‐Chih Wu Breakdown of academic impact, for papers by Barbara Claus Breakdown of academic impact, for papers by Jason W. Lancaster Breakdown of academic impact, for papers by Sara D. Brouse
Rankless by CCL
2026